develops after a surgical procedure and persists for at least 3 months after surgery, where all other causes of pain (eg, infection, recurring malignancy) or preexisting pain problems are excluded. [2] [3] [4] Possible pathologic factors leading to CPSP include inflammation, tissue and nerve damage, and altered central pain processing. 5, 6 Well-known preoperative and postoperative risk factors are preoperative pain, early postoperative pain, previous surgery, psychological factors or disorders, patient characteristics (ie, younger age and female gender), comorbidities, and alterations in central pain processing. 5, 6 In addition the surgical technique can influence the development of CPSP, which is possibly related to the extent of intraoperative nerve injury and adhesion formation. A laparoscopic technique might reduce intraoperative nerve damage; however, the literature on CPSP following laparoscopic vs open procedures is inconsistent. 6 Gerbershagen and colleagues described an incidence of CPSP following open nephrectomy (for benign and malignant renal disease) of 28.6% and 8.6%, after 3 and 6 months, respectively. 7 Another study by Alper et al 8 related quality of life (HRQoL) and daily activities, as described in patients who underwent gastrointestinal surgery. [11] [12] [13] To our knowledge, the impact of CPSP after LDN on HRQoL is unknown. The aim of this cross-sectional study was to explore the prevalence and risk factors of CPSP following LDN and its impact on the HRQoL.
| MATERIAL S AND ME THODS

| Study design and patient population
A cross-sectional study was performed among all living kidney donors who underwent a laparoscopic donor nephrectomy from January 2003
through December 2016 at the Radboud University Medical Center (Radboudumc) Nijmegen. All types of laparoscopic procedures were included. The gold standard at the Radboudumc is a transperitoneal approach; in selected cases the surgeon chooses a hand-assisted retroperitoneoscopic approach (HARP) or if needed a conversion to a hand-assisted laparoscopic donor nephrectomy (HALDN). Patients were eligible if they were able and willing to complete two questionnaires regarding chronic pain problems related to their donor nephrectomy and their HRQoL. All patients were approached by phone or mail, and after their consent they received the questionnaires and were asked to complete and return them. The study was approved by the medical ethics committee of the Radboudumc (2017-3110).
| Measures
The primary analysis consisted of the prevalence of CPSP following LDN. All included patients were asked if they still experienced pain related to their donor nephrectomy at the time that they were approached for this study. Patients were considered to have CPSP if their answer was "yes." In that case, the patients were asked to complete the Dutch version of the McGill Pain Questionnaire (MPQ). 14, 15 In addition, all included patients (with and without chronic pain)
were asked to fill in the Dutch version of the RAND Short Form-36
Health Status Inventory (RAND SF-36) regarding their HRQoL.
16,17
The MPQ is a validated multidimensional pain questionnaire designed to measure the quality and intensity of chronic pain.
14,15
The main section includes a list of 63 words, arranged in 20 categories, describing different aspects of the experienced pain, each with three or four intensity levels. These words are divided into three major classes, that is, the sensory class describing the sensory quality of the pain; the affective class describing affective qualities of pain, including tension, fear, and autonomic reactions to the pain experience; and the evaluative class, describing the subjective overall intensity of the pain. The quality of the pain is described by the chosen words specifically. Each word is accompanied with a value, based on its rank order within the word set of its category. per subscale, with higher scores indicating higher levels of functioning or well-being.
We obtained preoperative data on quality of life from a selection of our patient group, provided by Wirken and colleagues, who performed a study on predonation cognition of potential living organ donors between 2010 and 2011. 18 Therefore, we were able to compare preoperative and postoperative quality of life scores between patients with and without CPSP.
From all included patients, the medical records were reviewed to obtain information on their age during surgery, BMI, and relevant history, including previous abdominal surgery, preexisting pain problems (including spinal disc herniation and whiplash syndrome), and psychiatric disorders. In addition, perioperative and postoperative data were retrieved, including side of nephrectomy, duration of surgery, conversion to hand-assisted or open procedures, presence of severe early postoperative pain, analgesic use, postoperative complications, length of hospital stay, and readmissions within 3 months after surgery. We specified severe early postoperative pain as pain for which prolonged hospitalization (>5 days), prolonged opioid use (stated as continuation after discharge, which is not standard of care at our center), or anesthesia consultation for adequate pain management was necessary.
| Statistical analysis
Due to the design of this study, no sample size calculation was per- 
| Patient characteristics
The mean age ± SD at time of nephrectomy was 54.4 ± 9.9 years.
Forty-seven percent were male patients. The average length of followup after surgery was 75.2 ± 44.3 months. Patient characteristics are presented in Table 1 . We compared these patient characteristics with those of the nonrespondents group. The mean age of our respondents group was 6 years older, when compared to the nonrespondents group.
There were no statistically significant differences in gender distribution and average length of follow-up after surgery between the groups.
| Prevalence of CPSP
In the group of 512 living kidney donors, 29 patients (5.7%) reported the presence of chronic pain related to their donor nephrectomy.
The highest prevalence (12.2%) was reported in the group with a F I G U R E 1 Flowchart patient enrollment. LDN, laparoscopic donor nephrectomy follow-up time of 3 to 24 months after surgery. The prevalence of CPSP per follow-up interval is presented in Figure 2 .
| McGill Pain Questionnaire
Pain characteristics were evaluated by the MPQ, presented in Table 2 . Pain unset was slow in 16 patients (55.2%) and acute in 10 patients (34.5%). Various courses of pain were reported; most patients (48.3%) experienced continuous pain, differing in severity, but data are shown in Table 3 . Pain intensity was higher in younger pa- Within all 29 patients with CPSP following their LDN, there were no negative outcomes of the recipients (in all cases a well-functioning graft within the first year). Therefore, we conclude that it is unlikely that our results were influenced by the recipients' outcomes.
| Risk factors for the development of CPSP
| Health-related quality of life
The postoperative HRQoL of living kidney donors with CPSP was lower, when compared to donors without pain, as shown in Table 5 .
A major difference (32.6%) was seen with regard to role limitations Data were analyzed using analysis of variance (ANOVA). Variables are presented as mean ± standard deviation (SD). Significant P-values are in bold. PRI-T, total pain rating index (score 0-63).
TA B L E 3 PRI-T subgroup analyses
due to physical health problems between donors without CPSP (89.7% ± 27.5%) and donors with CPSP (57.1% ± 47.1%) (P = .001).
Furthermore, on the scale of bodily pain, the level of functioning in the group with CPSP was 20% lower (72.1 ± 21.6) when compared to donors without CPSP (92.1 ± 16.0), (P < .001), and also a reduction in energy of 18.3% was found in the patients with CPSP when compared to patients without CPSP (P < .001). Significant P values are in bold.
Variables are presented as mean ± SD. HRQoL, health-related quality of life.
TA B L E 5 HRQoL after donor nephrectomy (RAND SF-36)
due to physical health problems, in bodily pain, and in physical functioning. Preoperative and postoperative HRQoL scores of both groups are depicted in Figure 3 .
| D ISCUSS I ON
This is the first study on the prevalence of CPSP following LDN. In an open procedure. We performed additional analyses in which we excluded these patients (data not shown), which revealed no influence on our outcomes.
Because of our study design, we were able to compare the prevalence of CPSP in a large number of patients over different periods of time since surgery, with a mean follow-up time of 6.3 (± 3.7)
years. In the prospective study by Owen and colleagues, 9 all patients were approached 3 months after surgery. As shown in our patient group, the highest prevalence of CPSP was seen in this early period.
However, we showed that the complaints of CPSP are also found over longer periods, even after more than 10 years.
This study has some limitations. First, due to the crosssectional design, we could not assess the incidence of CPSP following LDN. The incidence of CPSP might be greater than 5.7%, as CPSP complaints may have resolved prior to the interview.
There is also a slight risk of recall bias, as patients with a shorter follow-up period might be more likely to attribute pain complaints to their donor nephrectomy, compared to patients in whom the surgery was more remote. Another limitation is that we received no response from 271 patients. There was a 6-year difference with the respondents group and the nonrespondents group, which might have influenced our results. Due to the cross-sectional design, we could not perform baseline preoperative measurements on the HRQoL. However, we obtained preoperative data on the HRQoL of 20% of the included patients. 18 The MPQ is a validated questionnaire. Despite this, there are different methods in the calculation of pain intensity scores, due to different language versions and adjusted short-form versions. Therefore, the PRI scores cannot be compared between versions of the MPQ. Nevertheless, our PRI scores can serve as reference values when using the Dutch language version. Furthermore, the MPQ is an ideal instrument to evaluate the effects of strategies to reduce CPSP following LDN in future studies. Finally,, due to the small number of events (29 patients with CPSP), there might be overestimation of the regression F I G U R E 3 HRQoL before and after LDN. HRQoL, health-related quality of life; LDN, laparoscopic donor nephrectomy coefficients in our multivariate analysis. However, our findings are in line with known risk factors for CPSP in general. 6 Prospective studies are needed for further investigation of risk factors for CPSP following LDN.
In conclusion, our unique data indicate that CPSP following LDN is a highly relevant issue. We found a substantial prevalence of CPSP of 5.7% following LDN. Given the possible association between the presence of CPSP and impaired HRQoL scores, living kidney donors should be well informed during the preoperative phase about the risk of CPSP. Prospective future studies should pursue strategies to reduce the incidence of CPSP after LDN.
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